Adults 20 to 65, any sex, with Occupational Therapy or Psychiatric Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Occupational Performance History Interview-II (OPHI-II) Total and Subscale ScoresPrimary· 2 weeks
The Occupational Performance History Interview-Second Version(OPHI-II) was tested before and after in the intervention group and the control group to explain the intervention effect of the MOHO theory-based treatment model.
OPHI-II is a semi-structured interview that gathers life history information. The OPHI-II contains 3 sub-domains: OPHI-II Occupational Identity(range 11\~44)、OPHI-II Occupational Competence(range 9\~36)、OPHI-II Occupational Behavior Settings(range 9\~36).
The three sub-domains are divided into 4 levels, in which 4 points indicate good performance, 3 points indicate good f
Except for Mini-Menlal State Examination(MMSE), all other tools were tested before and after in the intervention group and the control group to explain the intervention effect of the MOHO theory-based treatment model
The secondary outcome included the following instruments:
1. Mini-Menlal State Examination, MMSE(range 0\~30；the higher scores indicate greater ability)
2. Canadian Occupational Performance Measure, COPM(performance and satisfaction, each range 1\~10；the higher scores indicate greater performance)
3. Personal and Social Performance scale , PSP(range 1\~100；the higher scores indi
MMSE(pretest)
Group
Value
95% CI
Intervention Group
27.5
± 2.5
Control Group
27.8
± 2.5
CGIS(pretest)
Group
Value
95% CI
Intervention Group
3.9
± 0.8
Control Group
4.0
± 0.9
LIADL(pretest)
Group
Value
95% CI
Intervention Group
18.1
± 4.8
Control Group
17.8
± 4.2
COTES(pretest)
Group
Value
95% CI
Intervention Group
70.8
± 7.9
Control Group
74.9
± 7.8
COPM-C performance(pretest)
Group
Value
95% CI
Intervention Group
5.7
± 2.6
Control Group
5.1
± 2.3
COPM-C satisfaction(pretest)
Group
Value
95% CI
Intervention Group
5.5
± 2.9
Control Group
4.8
± 2.5
PSP(pretest)
Group
Value
95% CI
Intervention Group
52.1
± 15.9
Control Group
51.9
± 12.5
CGIS(posttest 2 weeks)
Group
Value
95% CI
Intervention Group
3.6
± 1.0
Control Group
3.4
± 1.0
Sponsor's own description
The purpose of the study is to develop and validate Client-centered Occupational Therapy Service at Taipei City Psychiatric Center (OT@tcpc) service model to assist clinicians to provide and integrate comprehensive OT services.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07501936 — Development of a Clinical Skills Teaching Video Database in Occupational Therapy
· recruiting
NCT06402942 — Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
· NA
· recruiting
NCT06820528 — Trapeziectomy and Suture Suspensionplasty for Thumb Carpometacarpal Arthritis - Is In-Clinic Therapy Needed?
· NA
· recruiting
NCT07092293 — Studying Rehabilitation Treatments Using Video to Improve Recovery for Adults With Physical Disabilities
· recruiting
NCT06749067 — Effect Of Awareness and Occupatıonal Practıces On Menopausal Women's Psychologıcal Wellbeıng And Menopausal Symptoms
· NA
· active not recruiting
Other Taipei City Hospital trials
Trials by the same sponsor.
NCT06337214 — TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy
· NA
· recruiting
NCT07501546 — Enhancing Childhood Obesity Interventions Through Digital Media Tools
· NA
· completed
NCT06139276 — Outcomes of Frozen Shoulder Treated With Small Needle-Knife Through Microcirculation and Pulse Analysis.
· NA
· unknown
NCT06100198 — The Effect of Nutrition and Exercise Program on the Health of Community-dwelling Older Adults
· NA
· unknown
NCT07105761 — Body-Mind-Spirit Action Group on the Well-being
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei City Hospital
Last refreshed: 24 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04465422.